Iran has the ability to continue its peaceful nuclear energy program and improve its international ties at the same time, Velayati said.
Velayati, who currently serves as a senior advisor to Supreme Leader of the Islamic Revolution Ayatollah Seyed Ali Khamenei, said that issues of dispute can be negotiated and his government will be able to proceed with the nuclear energy program while protecting its achievements.
One of the members of the '2+1 Coalition', which is comprised of Tehran Mayor Mohammad Baqer Qalibf, member of the Iranian Parliament Gholam-Ali Haddad Adel, and Velayati, will run in the June presidential election.
On November 23, the 17th Exhibition of Iran's achievement in nuclear industry started work at Shahid Baheshti University here in Tehran to display the country's latest nuclear achievements.
Part of the Iranian nuclear industry's achievements in nuclear fuel production and enrichment, Bushehr nuclear power plant and Arak nuclear research reactor, nuclear agriculture, nuclear and radio medicine, nuclear fusion, optic, laser and nuclear materials were on display in the exhibition.
The exhibition allocated one of its pavilions for introducing 360MW Darkhovin power plant (IR360) to the public and enthusiasts.
Various Iranian universities across the country have so far hosted similar exhibitions aimed at introducing Iran's peaceful nuclear technology to citizens.
The event also marked anniversary of the assassination of Iranian nuclear scientist and university professor Dr. Majid Shahriari, who was killed in a terrorist bomb attack here in Tehran on November 29, 2010.
Iran in December unveiled five different radiomedicine projects with applications for diagnosis, prevention and treatment of a number of diseases.
In September, Iran announced that it plans to synthesize 20 kinds of radiomedicine inside the country, stressing that its scientists are capable of supplying the 20%-enriched uranium needed for the production of such drugs.
"Iran has gained the necessary preparedness to produce 20 radiomedicines and we will provide the 20% (enriched) fuel needed for the production of these medicines this year," Deputy Head of the Atomic Energy Organization of Iran (AEOI) for Planning, International and Parliamentary Affairs Massoud Akhavan-Fard told FNA in September.
In addition to the Tehran research reactor which has long been used by radioisotope production, Iran plans to build four other research reactors in the other parts of the country, he added.